Reason for request
Reassessment of the actual benefit (AB) and improvement in actual benefit (IAB).
Clinical Benefit
| Substantial |
The actual benefit of VERSATIS is substantial. |
Clinical Added Value
| minor |
The new clinical data available indicates that VERSATIS provides a minor improvement in actual benefit (level IV) in the management of post-herpetic pain in adults. |
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
tpBfy1xgDSeZrw1X
